Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
4.120
-0.010 (-0.24%)
At close: Oct 2, 2026, 4:00 PM EDT
4.115
-0.005 (-0.12%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Adial Pharmaceuticals Earnings Call Transcripts
Fiscal Year 2026
-
The acquisition brings a novel, colon-targeted therapy for ulcerative colitis and up to $64M in financing, with Azora equity holders gaining majority ownership. The combined company will focus on advancing AT177 through early clinical milestones.